Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Interpace Diagnostics Group Inc (NASDAQ:IDXG)

4.33
Delayed Data
As of Jan 20
 -0.27 / -5.87%
Today’s Change
0.70
Today|||52-Week Range
19.80
-1.59%
Year-to-Date
12 Biggest Mid-Day Gainers For Friday
Jan 20 / Benzinga - Paid Partner Content
 

Today’s Trading

Previous close4.60
Today’s open7.13
Day’s range4.26 - 7.48
Volume6,360,228
Average volume (3 months)765,967
Market cap$12.1M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-97.39%
Earnings growth (this year)+65.17%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-92.14%
P/E ratioNM
Price/Sales0.76
Price/Book0.59

Competitors

 Today’s
change
Today’s
% change
GALTUGalectin Therapeutic...-0.57-7.29%
APHBAmpliPhi Biosciences...+0.01+2.81%
BMRABiomerica Inc+0.20+8.44%
----
Data as of 4:01pm ET, 01/20/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.4M
Annual profit (last year)-$33.0M
Net profit margin-329.41%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Jack E. Stover
Chief Financial Officer
James Early
Corporate headquarters
Parsippany, New Jersey

Forecasts


Search for Jobs